Colinz Laboratories Q4 Results

  • BSE: 531210
  • NSE: -
  • ISIN: INE923C01011
  • Sector: Biotechnology & Drugs
BSE
53.5-1.52 (-2.76%)
Volume1.88 K
Updated: Mon 25 Nov, 2024 | 15:22:52
NSE
This stock is not traded on NSE
Today: 52.27
55.02
52-Wk: 36.00
84.40

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Colinz Laboratories Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 1.631.68-%1.72-%
    Selling/ General/ Admin Expenses Total 0.600.77-%0.71-%
    Depreciation/ Amortization 0.030.03-%0.03-%
    Other Operating Expenses Total 0.310.28-%0.28-%
    Total Operating Expense 1.541.58-%1.59-%
    Operating Income 0.090.10-%0.13-%
    Net Income Before Taxes 0.190.13-%0.16-%
    Net Income 0.140.10-%0.13-%
    Diluted Normalized EPS 0.540.41-%0.51-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts